• Reference Citation Analysis
  • v
  • v
  • Find an Article
  • Find an Author
Download
Number Citation Analysis
1
Puppe J, Brambillasca C, Ratz L, Bartke L, van de Ven M, Bouwman P, van Tellingen O, Isensee J, Hucho T, van Lohuizen M, Malter W, Schmutzler R, Mallmann P, Jonkers J, Reinhardt C. Dual inhibition of EZH2 and ATM displays synergistic cytotoxicity in BRCA1-deficient breast cancers. Geburtshilfe Frauenheilkd 2020. [DOI: 10.1055/s-0040-1717869] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]  Open
2
Pulver E, Moisés da Silva A, Bouwman P, Annunziato S, Jonkers J. PO-333 Somatic engineering of mammary gland epithelial cells using CRISPR/Cas9 for rapid testing of breast cancer susceptibility genes in mouse models. ESMO Open 2018. [DOI: 10.1136/esmoopen-2018-eacr25.363] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]  Open
3
Kousholt A, Bouwman P, Jonkers J. PO-205 Functional characterisation of BRIP1/FANCJ in tumour suppression and therapy response. ESMO Open 2018. [DOI: 10.1136/esmoopen-2018-eacr25.723] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]  Open
4
Puppe J, van de Ven M, van der Burg E, Boon U, van Tellingen O, Bouwman P, Mallmann P, Schmutzler R, van Lohuizen M, Jonkers J. EZH2 inhibition sensitizes BRCA1-deficient breast tumors to the PI3K inhibitor BKM120. Geburtshilfe Frauenheilkd 2016. [DOI: 10.1055/s-0036-1593269] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]  Open
5
Puppe J, ter Brugge P, Seressi M, van Tellingen O, van der Burg E, Boon U, Bouwman P, Mallmann P, Schmutzler R, van Lohuizen M, Jonkers J. Combination therapy of the EZH2 inhibitor GSK126 and the PARP inhibitor Olaparib shows in vivo synergy in a patient-derived xenograft model of BRCA1-deficient breast cancer. Geburtshilfe Frauenheilkd 2014. [DOI: 10.1055/s-0034-1388546] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]  Open
6
Rottenberg S, Jaspers J, Drost R, Bouwman P, O'Connor M, Borst P, Jonkers J. 381 INVITED Preclinical Evaluation of PARP Inhibitors in Mouse Models of Human Breast Cancer. Eur J Cancer 2011. [DOI: 10.1016/s0959-8049(11)70596-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
7
Drost R, Bouwman P, Van der Gulden H, Van der Burg E, Jonkers J. The impact of defined Brca1 mutations on tumor development, drug response and acquired resistance. EJC Suppl 2008. [DOI: 10.1016/s1359-6349(08)71213-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]  Open
8
Göllner H, Bouwman P, Mangold M, Karis A, Braun H, Rohner I, Del Rey A, Besedovsky HO, Meinhardt A, van den Broek M, Cutforth T, Grosveld F, Philipsen S, Suske G. Complex phenotype of mice homozygous for a null mutation in the Sp4 transcription factor gene. Genes Cells 2001;6:689-97. [PMID: 11532028 DOI: 10.1046/j.1365-2443.2001.00455.x] [Citation(s) in RCA: 49] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
9
Bouwman P, Göllner H, Elsässer HP, Eckhoff G, Karis A, Grosveld F, Philipsen S, Suske G. Transcription factor Sp3 is essential for post-natal survival and late tooth development. EMBO J 2000;19:655-61. [PMID: 10675334 PMCID: PMC305603 DOI: 10.1093/emboj/19.4.655] [Citation(s) in RCA: 154] [Impact Index Per Article: 6.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022]  Open
PrevPage 1 of 1 1Next
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA